Title:
GPR103-like受容体蛋白質に対するリガンドの新規用途
Document Type and Number:
Japanese Patent JP4760377
Kind Code:
B2
Abstract:
It is intended to clarify the relevancy between NPX and pathological conditions and develop a drug having a novel function mechanism never achieved by the existing ones by using NPX either directly or in screening. Thus, an antidepressant drug or an anxiolytic drug containing a peptide which comprises an amino acid sequence represented by SEQ ID NO:1 or 3 is provided.
Inventors:
Okuyama Shigeru
Tatsuya Onuki
Tatsuya Onuki
Application Number:
JP2005516920A
Publication Date:
August 31, 2011
Filing Date:
January 07, 2005
Export Citation:
Assignee:
Taisho Pharmaceutical Co., Ltd.
International Classes:
A61K38/00; A61K38/16; A61P25/24; C07K14/47; G01N33/94
Foreign References:
| WO2003020932A1 | 2003-03-13 |
Attorney, Agent or Firm:
Patent Service Corporation Patent Office Sykes